Linking those pieces of evidence to our findings, the IgG repertoire induced in ATLL patients may play a protective role by mediating a negative regulation of IL-4 production that may negatively impact the proliferation of leukemic cells. This evidence concerns the gene IL4 and adult T-cell leukemia/lymphoma.